Cita APA

Khurshed, M., Aarnoudse, N., Hulsbos, R., Hira, V. V. V., van Laarhoven, H. W. M., Wilmink, J. W., . . . van Noorden, C. J. F. (2018). IDH1-mutant cancer cells are sensitive to cisplatin and an IDH1-mutant inhibitor counteracts this sensitivity. FASEB J.

Citación estilo Chicago

Khurshed, Mohammed, Niels Aarnoudse, Renske Hulsbos, Vashendriya V. V. Hira, Hanneke W. M. van Laarhoven, Johanna W. Wilmink, Remco J. Molenaar, y Cornelis J. F. van Noorden. "IDH1-mutant Cancer Cells Are Sensitive to Cisplatin and an IDH1-mutant Inhibitor Counteracts This Sensitivity." FASEB J 2018.

Cita MLA

Khurshed, Mohammed, et al. "IDH1-mutant Cancer Cells Are Sensitive to Cisplatin and an IDH1-mutant Inhibitor Counteracts This Sensitivity." FASEB J 2018.